The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

Recruiting N/A Interventional Study
Pneumonia Necrotizing Soft Tissue Infection Intraabdominal Infections Infection Joint
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
144 (estimated)
Sponsor
Washington University School of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Our data suggest that modulating the characteristics of light carries the potential to modify the host response to injury and critical illness and thus, improve outcome. The ability to modify the host response to the stress of major operations and sepsis carries immense potential to improve patient care. The primary purpose of this study is to determine if exposure to bright blue (442nm) enriched…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * greater than or equal to 18 years of age and less than or equal to 65 years of age * one of the following diagnoses requiring inpatient hospital care 1. an operation for intraabdominal infection 2. an operation for necrotizing soft tissue infection 3. an operation for a…
Contacts

Matthew R Rosengart, MD MPH

314-362-5298

matthew.r@wustl.edu

CONTACT

Xianghong Zhang, PhD

412-215-6134

xianghong@wustl.edu

CONTACT